Cargando…

MicroRNAs in pancreatic cancer diagnosis and therapy

Pancreatic cancer remains a disease with very poor prognosis (only 5-6% of patients are still alive after five years). Attempts to improve the results of treatment of pancreatic cancer focus on a better understanding of the pathogenesis, and non-invasive diagnostic methods (genetic testing from peri...

Descripción completa

Detalles Bibliográficos
Autores principales: Słotwiński, Robert, Lech, Gustaw, Słotwińska, Sylwia Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Society of Experimental and Clinical Immunology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305615/
https://www.ncbi.nlm.nih.gov/pubmed/30588176
http://dx.doi.org/10.5114/ceji.2018.80051